Sunshine Biopharma, Inc. (SBFM)

NASDAQ: SBFM · IEX Real-Time Price · USD

0.320

-0.082 (-20.48%)

At close: Jul 2, 2024, 4:00 PM

0.333

+0.013 (4.00%)

After-hours: Jul 2, 2024, 7:54 PM EDT

Sunshine Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018 - 2008
Market Capitalization	6	7	14	30	5	0	Upgrade
Market Cap Growth	-63.55%	-51.77%	-52.01%	477.16%	2129.77%	-82.08%	Upgrade
Enterprise Value	-11	-9	-7	30	6	1	Upgrade
PE Ratio	-	-1.55	-0.54	-2.42	-1.87	-0.14	Upgrade
PS Ratio	0.23	0.29	3.33	131.87	73.08	11.08	Upgrade
PB Ratio	0.24	0.33	0.67	142.31	-5.47	-0.32	Upgrade
P/FCF Ratio	-0.59	-0.80	-2.67	-16.47	-7.93	-0.47	Upgrade
P/OCF Ratio	-0.60	-0.79	-2.75	-16.47	-7.94	-0.47	Upgrade
EV/Sales Ratio	-0.40	-0.36	-1.52	131.20	85.91	42.68	Upgrade
EV/EBITDA Ratio	3.17	2.27	0.25	-2.48	-2.36	-0.59	Upgrade
EV/EBIT Ratio	3.03	2.18	0.25	-2.48	-2.35	-0.58	Upgrade
EV/FCF Ratio	1.07	0.99	1.22	-16.38	-9.32	-1.82	Upgrade
Debt / Equity Ratio	0.02	0.03	0.04	8.98	-2.00	-0.97	Upgrade
Debt / EBITDA Ratio	-0.18	-0.17	-0.03	-0.16	-0.74	-0.47	Upgrade
Debt / FCF Ratio	-0.06	-0.08	-0.14	-1.04	-2.91	-1.44	Upgrade
Quick Ratio	3.10	3.39	3.42	22.59	0.95	0.06	Upgrade
Current Ratio	4.41	4.48	3.94	24.07	0.98	0.08	Upgrade
Asset Turnover	0.93	0.87	0.14	0.11	0.16	0.05	Upgrade
Interest Coverage	-24.56	-28.94	-671.67	-36.82	-15.56	-13.33	Upgrade
Return on Equity (ROE)	-17.90%	-21.00%	-91.30%	1704.00%	405.60%	265.00%	Upgrade
Return on Assets (ROA)	-14.20%	-16.30%	-85.20%	-593.60%	-619.30%	-414.90%	Upgrade
Return on Capital (ROIC)	-16.94%	-21.89%	-120.58%	-115.56%	-60.20%	3237.81%	Upgrade
Earnings Yield	-67.34%	-64.63%	-185.02%	-41.29%	-53.35%	-709.35%	Upgrade
FCF Yield	-166.81%	-125.16%	-37.42%	-6.07%	-12.62%	-212.19%	Upgrade
Buyback Yield / Dilution	-191.02%	-60.28%	-481.18%	-155.96%	-1765.63%	-259.87%	Upgrade
Total Shareholder Return	-191.02%	-60.28%	-481.18%	-155.96%	-1765.63%	-259.87%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).